21 completed, 3 terminated, 3 unknown, 2 active not recruiting. 10 Phase 1, 10 Phase 2, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 7, Active not recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 10 | Completed 7, Unknown 2, Terminated 1 |
| Phase 3 | 4 | Completed 3, Active not recruiting 1 |
Follow Anterogen Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L ANT-301 - Osteoarthritis, Knee | Phase 1 | Active not recruiting | Anterogen Co., Ltd. | 6 | 2024-10-22 | 2025-09-22 |
| Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa ALLO-ASC-SHEET, Vehicle Control - Dystrophic Epidermolysis Bullosa | Phase 2 | Unknown | Anterogen Co., Ltd. | 6 | 2023-05-01 | 2024-04-22 |
| A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial ALLO-ASC-DFU, Vehicle sheet - Diabetic Foot Ulcer | Recruiting | Anterogen Co., Ltd. | 104 | 2023-04-25 | 2024-12-13 | |
| Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers ALLO-ASC-SHEET - Diabetic Foot Ulcer | Phase 2 | Unknown | Anterogen Co., Ltd. | 64 | 2020-09-08 | 2023-08-24 |
| Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers. ALLO-ASC-DFU, Vehicle Sheet - Diabetic Foot Ulcer | Phase 3 | Completed | Anterogen Co., Ltd. | 104 | 2020-07-14 | 2025-09-22 |
| A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial ALLO-ASC-DFU, Vehicle sheet - Diabetic Foot Ulcer | Completed | Anterogen Co., Ltd. | 73 | 2020-06-24 | 2023-08-25 | |
| Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula ASC, Fibringlue - Crohn's Fistula | Phase 3 | Active not recruiting | Anterogen Co., Ltd. | 46 | 2020-01-09 | 2025-09-29 |
| Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers ALLO-ASC-DFU, Hydrogel SHEET(Vehicle control) - Diabetic Foot Ulcer | Phase 2 | Completed | Anterogen Co., Ltd. | 66 | 2019-01-02 | 2025-01-23 |
| Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers. ALLO-ASC-DFU, Vehicle sheet - Diabetic Foot Ulcer | Phase 3 | Completed | Anterogen Co., Ltd. | 150 | 2018-06-27 | 2023-08-25 |
| A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial ALLO-ASC-DFU - Dystrophic Epidermolysis Bullosa | Completed | Anterogen Co., Ltd. | 2 | 2017-12-08 | 2023-08-25 | |
| A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial ALLO-ASC-CD - Crohn Disease | Recruiting | Anterogen Co., Ltd. | 9 | 2016-11-16 | 2023-08-25 | |
| A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial ALLO-ASC-DFU - Burn | Completed | Anterogen Co., Ltd. | 14 | 2016-08-29 | 2023-08-25 | |
| A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial ALLO-ASC-DFU - Diabetic Foot Ulcer | Completed | Anterogen Co., Ltd. | 4 | 2016-01-11 | 2018-01-10 | |
| A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial ALLO-ASC-DFU, Standard therapy - Diabetic Foot Ulcer | Completed | Anterogen Co., Ltd. | 54 | 2015-12-29 | 2023-08-25 | |
| A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects ALLO-ASC-DFU, Conventional Therapy - Burn Injury | Phase 2 | Completed | Anterogen Co., Ltd. | 20 | 2015-12-23 | 2023-08-25 |
| Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa Allogeneic mesenchymal stem cells, Polyurethene Film - Dystrophic Epidermolysis Bullosa | Phase 1 / Phase 2 | Completed | Anterogen Co., Ltd. | 2 | 2015-12-08 | 2023-08-25 |
| A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease ALLO-ASC - Crohn's Disease | Phase 1 | Unknown | Anterogen Co., Ltd. | 9 | 2015-11-09 | 2023-08-25 |
| A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial ALLO-ASC-DFU - Burn | Completed | Anterogen Co., Ltd. | 5 | 2015-11-01 | 2018-01-10 | |
| Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers ALLO-ASC-DFU, Standard therapy - Diabetic Foot Ulcer | Phase 2 | Completed | Anterogen Co., Ltd. | 59 | 2015-10-01 | 2017-09-01 |
| A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound ALLO-ASC-DFU - Burn | Phase 1 | Completed | Anterogen Co., Ltd. | 5 | 2015-03-01 | 2015-12-30 |
Showing 20 of 31. Sign in to see all of them.
Diabetic Foot (10) · Crohn Disease (5) · Burns (4) · Epidermolysis Bullosa Dystrophica (3) · Fistula (3) · Epidermolysis Bullosa (2) · Fecal Incontinence (1) · Osteoarthritis, Knee (1) · Tennis Elbow (1)
Population Groups (2) · Standard of Care (2) · Saline Solution (1)
South Korea (27) · United States (3)
DS Kim (2) · JiUng Bak, MD. Ph D (2) · Ki-Won Young, MD. Ph D. (2) · Seung-Kyu Han, MD. Ph D. (2) · Wook Chun, MD, PhD (2) · Wook Chun, PhD (2) · Alexander M. Reyzelman, DPM (1) · BaekKyu Kim, MD. Ph D (1) · CS You, MD, PhD (1) · CS Yu, MD, PhD (1) · Chan Kang, MD. Ph D. (1) · ChanYeong Heo, MD. Ph D. (1) · ChangSik Park, MD. Ph D (1) · ChangSik Yu, MD. Ph D (1) · Changsik Park, MD. Ph D. (1)